External validation and reproducibility of the PUMA questionnaire for the diagnosis of COPD in a Latin American population: External validation of the PUMA questionnaire
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Abstract
The use of clinical prediction scales may increase the early detection of chronic obstructive pulmonary disease (COPD). The performance characteristics of these scales in the Latin American population is poorly studied. We aimed to evaluate validity and reproducibility of PUMA question- naire as a screening tool in primary care in a Colombian population. A cross-sectional study was performed. Operational characteristics of the questionnaire, the area under the received operator curve (AUROC), and the best cut-off point of the score were calculated. 1,980 individuals were included in this analysis. Prevalence of COPD was 18.9%. AUROC of the questionary was 0.69 (CI95%: 0.66-0.72), with an optimal cut-off point greater than 5 (sensitivity 60%, specificity 66%); predictive negative value was 88%. PUMA’s scale for the screening of patients at risk of COPD has a moderate accuracy and an excellent reproducibility in the studied population.
##plugins.themes.bootstrap3.article.details##
Pulmonary Disease, Chronic Obstructive, Surveys and Questionnaires, Prevalence, Reproducibility of Results, Cross-sectional Studies
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
